Revolution Medicines, Inc. Warrant (RVMDW)
USD 0.04
(-0.5%)
USD 0.04
(-0.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -430.58 Million USD | -91.82% |
| 2022 | -239.46 Million USD | -33.17% |
| 2021 | -179.74 Million USD | -72.49% |
| 2020 | -101.91 Million USD | -123.22% |
| 2019 | -48.58 Million USD | -21.75% |
| 2018 | -39.9 Million USD | -33.76% |
| 2017 | -29.83 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -154.93 Million USD | -11.18% |
| 2024 Q1 | -139.35 Million USD | 11.99% |
| 2023 Q1 | -75.15 Million USD | -32.72% |
| 2023 Q3 | -123.24 Million USD | -13.28% |
| 2023 Q2 | -108.79 Million USD | -44.76% |
| 2023 FY | - USD | -91.82% |
| 2023 Q4 | -177.12 Million USD | -43.71% |
| 2022 Q1 | -58.88 Million USD | -6.38% |
| 2022 FY | - USD | -33.17% |
| 2022 Q4 | -75.15 Million USD | -32.72% |
| 2022 Q2 | -71.19 Million USD | -20.9% |
| 2022 Q3 | -56.63 Million USD | 20.46% |
| 2021 FY | - USD | -72.49% |
| 2021 Q4 | -55.35 Million USD | -5.09% |
| 2021 Q3 | -52.67 Million USD | -2.9% |
| 2021 Q2 | -51.18 Million USD | -20.56% |
| 2021 Q1 | -42.45 Million USD | -19.65% |
| 2020 Q2 | -25.57 Million USD | 0.04% |
| 2020 Q1 | -25.58 Million USD | -37.33% |
| 2020 FY | - USD | -123.22% |
| 2020 Q4 | -35.48 Million USD | -4.9% |
| 2020 Q3 | -33.82 Million USD | -32.27% |
| 2019 Q4 | -18.62 Million USD | -3.03% |
| 2019 FY | - USD | -21.75% |
| 2019 Q3 | -18.08 Million USD | -51.69% |
| 2019 Q2 | -11.92 Million USD | -28.45% |
| 2019 Q1 | -9.28 Million USD | 0.3% |
| 2018 Q4 | -9.3 Million USD | 12.31% |
| 2018 Q3 | -10.61 Million USD | 0.0% |
| 2018 FY | - USD | -33.76% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -124.077% |
| Alkermes plc | 495.04 Million USD | 186.978% |
| Agenus Inc. | -145.92 Million USD | -195.073% |
| Aptorum Group Limited | -9.59 Million USD | -4385.698% |
| Ardelyx, Inc. | -55.35 Million USD | -677.87% |
| Dyadic International, Inc. | -8.22 Million USD | -5132.025% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -147866.323% |
| Lantern Pharma Inc. | -15.78 Million USD | -2627.5% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2062.382% |
| Novavax, Inc. | -487.39 Million USD | 11.656% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -506.249% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -448.561% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2295.656% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4219.643% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -650.458% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -13.32% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1685.766% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 81495.463% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -173.916% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -475.53% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2035.929% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1714.123% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1767.387% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -252.638% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -66.736% |
| AlloVir, Inc. | -190.14 Million USD | -126.448% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -145.106% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1371.673% |
| Bicycle Therapeutics plc | -183.4 Million USD | -134.778% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -160.295% |
| ChromaDex Corporation | -3.89 Million USD | -10957.576% |
| Chimerix, Inc. | -92.97 Million USD | -363.121% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -868.978% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -282.624% |
| CRISPR Therapeutics AG | -202.7 Million USD | -112.422% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1243.805% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -150.006% |
| Fortress Biotech, Inc. | -133.64 Million USD | -222.188% |
| Fortress Biotech, Inc. | -133.64 Million USD | -222.188% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -456.717% |
| ImmuCell Corporation | -2.5 Million USD | -17095.238% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -230.148% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2568.514% |
| Incyte Corporation | 919.42 Million USD | 146.832% |
| Innoviva, Inc. | 248.96 Million USD | 272.952% |
| IO Biotech, Inc. | -91.22 Million USD | -371.984% |
| Jaguar Health, Inc. | -33.13 Million USD | -1199.635% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -182.948% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 523.272% |
| ContextLogic Inc. | -324 Million USD | -32.896% |
| MiMedx Group, Inc. | 40.51 Million USD | 1162.719% |
| MEI Pharma, Inc. | 26.38 Million USD | 1732.229% |
| NextCure, Inc. | -59.03 Million USD | -629.318% |
| Onconetix, Inc. | -36.7 Million USD | -1073.033% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 19365.414% |
| Opthea Limited | -200.01 Million USD | -115.271% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -15548.536% |
| Vaxcyte, Inc. | -464.88 Million USD | 7.379% |
| PDS Biotechnology Corporation | -40.08 Million USD | -974.173% |
| Precigen, Inc. | -89.22 Million USD | -382.575% |
| Pharming Group N.V. | 9.87 Million USD | 4459.441% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -170.723% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1791.67% |
| PureTech Health plc | -11.62 Million USD | -3603.294% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2435.669% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -84.406% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1685.766% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -392.505% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1386.662% |
| Acelyrin, Inc. | -381.52 Million USD | -12.858% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3341659.223% |
| Summit Therapeutics Inc. | 1 Million USD | 43115.185% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1189.708% |
| Senti Biosciences, Inc. | -61.33 Million USD | -602.005% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -283.408% |
| Elevation Oncology, Inc. | -41.46 Million USD | -938.373% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1293.289% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -6939.627% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -134037.695% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1226.786% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5028.418% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -632.407% |
| Seer, Inc. | -97.88 Million USD | -339.886% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -592.287% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -558.735% |
| ESSA Pharma Inc. | -26.45 Million USD | -1527.583% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1000.614% |
| GT Biopharma, Inc. | 5.97 Million USD | 7301.572% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -108.32% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6169.394% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 595.994% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -658.681% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -740.669% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4255.074% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 20.252% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6154.823% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -818.83% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -81.97% |
| Aptose Biosciences Inc. | -52.26 Million USD | -723.797% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -299.637% |
| Soligenix, Inc. | -7.85 Million USD | -5383.13% |
| Century Therapeutics, Inc. | -121.2 Million USD | -255.242% |
| Kura Oncology, Inc. | -164.95 Million USD | -161.03% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -437.569% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4169.106% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -44858.178% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -9892.62% |
| Autolus Therapeutics plc | -156.77 Million USD | -174.658% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -408.619% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -524.023% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2060.038% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -127.493% |
| GRI Bio, Inc. | -10.89 Million USD | -3851.019% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9435.19% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -251.478% |
| IGM Biosciences, Inc. | -253.35 Million USD | -69.95% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -314.851% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1029.152% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2708.588% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2635.028% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -657.467% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -302.026% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -61.875% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -122.019% |
| Verastem, Inc. | -83.16 Million USD | -417.738% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -751.424% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -172.128% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -277.409% |
| Histogen Inc. | -10.5 Million USD | -3999.61% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2915.342% |
| Surrozen, Inc. | -41.13 Million USD | -946.855% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2808.159% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13426417.431% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -633.365% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -739.439% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1899.081% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5064.089% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -159.283% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -774.128% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1681.768% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2760.052% |
| Apollomics, Inc. | -171.74 Million USD | -150.707% |
| Amarin Corporation plc | -50.9 Million USD | -745.912% |
| Mesoblast Limited | -61.33 Million USD | -602.063% |
| Turnstone Biologics Corp. | -56.23 Million USD | -665.697% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -200.684% |
| Synaptogenix, Inc. | -8.3 Million USD | -5083.047% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2707.106% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -582.954% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8886.435% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 100459.641% |
| Exelixis, Inc. | 196.6 Million USD | 319.012% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1025.352% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -204.494% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 13.051% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3550.344% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 174272.384% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1359.303% |
| Gritstone bio, Inc. | -126.86 Million USD | -239.407% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -562.587% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -10664.695% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3650.388% |
| Insmed Incorporated | -654.73 Million USD | 34.236% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -19039.368% |
| MediWound Ltd. | -4.89 Million USD | -8699.959% |
| OmniAb, Inc. | -49.73 Million USD | -765.822% |
| Alector, Inc. | -142.89 Million USD | -201.334% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -403.994% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -725.692% |
| Zai Lab Limited | -366.57 Million USD | -17.461% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -48.151% |
| Aura Biosciences, Inc. | -83.69 Million USD | -414.459% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -91.158% |
| Immunic, Inc. | -99.11 Million USD | -334.44% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -227.016% |
| Veracyte, Inc. | -49.4 Million USD | -771.465% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5995.501% |
| FibroGen, Inc. | -261.4 Million USD | -64.718% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3764.842% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6050.005% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2200.503% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 129.707% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1593.738% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1179.423% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1749.739% |
| Galecto, Inc. | -37.51 Million USD | -1047.637% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1025.263% |
| Fortrea Holdings Inc. | 167.3 Million USD | 357.371% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -220.66% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1420.9% |
| XBiotech Inc. | -35.76 Million USD | -1103.886% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -562.587% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -559.896% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -312.218% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1577.244% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -953.618% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 16.627% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -668.608% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -768096.821% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -270.122% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1842.222% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -83.176% |
| NexImmune, Inc. | -28.16 Million USD | -1428.648% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -7692.566% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3551.391% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 109.251% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1595.739% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3576.057% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -242.15% |
| Ainos, Inc. | -8.77 Million USD | -4807.981% |
| Pluri Inc. | -20.22 Million USD | -2028.959% |
| Prothena Corporation plc | -190.1 Million USD | -126.493% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -235.873% |
| Celularity Inc. | -183.94 Million USD | -134.081% |
| Rallybio Corporation | -72.37 Million USD | -494.948% |
| Cue Biopharma, Inc. | -46.05 Million USD | -834.991% |
| MeiraGTx Holdings plc | -57.05 Million USD | -654.719% |
| Omeros Corporation | -163.61 Million USD | -163.176% |
| Humacyte, Inc. | -96.45 Million USD | -346.393% |
| Immunocore Holdings plc | -59.64 Million USD | -621.86% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2122.703% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1667.215% |
| Blueprint Medicines Corporation | -474.61 Million USD | 9.277% |
| CalciMedica, Inc. | -34.18 Million USD | -1159.417% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -487.954% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -243.101% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -155.613% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -70.602% |
| Pulmatrix, Inc. | -12.64 Million USD | -3304.887% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1206.14% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -386.715% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 14.958% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -325.413% |
| Cytokinetics, Incorporated | -456.68 Million USD | 5.716% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1190.211% |
| Nutriband Inc. | -5.12 Million USD | -8306.887% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -895.059% |
| Vor Biopharma Inc. | -114.37 Million USD | -276.478% |
| Roivant Sciences Ltd. | -996.51 Million USD | 56.791% |
| Evogene Ltd. | -23.2 Million USD | -1755.637% |
| ProKidney Corp. | -147.66 Million USD | -191.586% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -567.207% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -281052.342% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 23.854% |
| CorMedix Inc. | -48.88 Million USD | -780.769% |
| BioLineRx Ltd. | -57.06 Million USD | -654.599% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -285.281% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -213059.406% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1085.817% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -441.497% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -429.536% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -56.289% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1300.722% |
| MediciNova, Inc. | -9.87 Million USD | -4258.131% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -241.892% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28038.918% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1514.555% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -91.377% |
| Biomea Fusion, Inc. | -124.62 Million USD | -245.516% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -30.345% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1552.525% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -126.218% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -87.257% |
| Absci Corporation | -95.45 Million USD | -351.074% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1334.078% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -301.97% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -84.422% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1783.973% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -107.174% |
| Allakos Inc. | -189.91 Million USD | -126.724% |
| Imunon, Inc. | -19.87 Million USD | -2066.093% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -296.879% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 497.495% |
| BioAtla, Inc. | -122.24 Million USD | -252.24% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3550.344% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2631.946% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -43.387% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -938.874% |
| XOMA Corporation | -39.36 Million USD | -993.903% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -333.818% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -265.986% |
| aTyr Pharma, Inc. | -52.17 Million USD | -725.218% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -413.729% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -189.699% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -83.566% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3053.754% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5253.966% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2462.683% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 228276.105% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 195.273% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6639.823% |
| UroGen Pharma Ltd. | -63.83 Million USD | -574.566% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -534.001% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5828.422% |
| Orgenesis Inc. | -60.71 Million USD | -609.15% |
| Entera Bio Ltd. | -8.8 Million USD | -4790.754% |
| GH Research PLC | -41.15 Million USD | -946.296% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1587.3% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -423.612% |
| Xencor, Inc. | -125.87 Million USD | -242.074% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -30083.555% |
| Replimune Group, Inc. | -230.19 Million USD | -87.049% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2036.076% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3835.131% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6639.823% |
| Portage Biotech Inc. | -18.19 Million USD | -2265.965% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28038.918% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -311.709% |
| OncoCyte Corporation | -23.12 Million USD | -1762.137% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3710.338% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3658.297% |
| Purple Biotech Ltd. | -22.22 Million USD | -1837.377% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -6617.348% |
| scPharmaceuticals Inc. | -46.06 Million USD | -834.808% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2317.685% |
| HilleVax, Inc. | -132.46 Million USD | -225.051% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3949.487% |
| Tharimmune, Inc. | -9.3 Million USD | -4528.625% |
| Genprex, Inc. | -31.06 Million USD | -1286.266% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -129.612% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1273.292% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -56258.901% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 285435.047% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2734471.034% |
| Savara Inc. | -59.13 Million USD | -628.159% |
| Curis, Inc. | -45.13 Million USD | -853.902% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1302.478% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2734.427% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5909.518% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1510.616% |
| BeiGene, Ltd. | -1.12 Billion USD | 61.713% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2541.413% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -376.624% |
| Erasca, Inc. | -121.31 Million USD | -254.944% |
| bluebird bio, Inc. | -167.16 Million USD | -157.585% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9471.135% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 238.77% |
| DBV Technologies S.A. | -85.98 Million USD | -400.782% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9471.135% |
| Moderna, Inc. | -3.28 Billion USD | 86.884% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -910.542% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -7523.619% |
| Molecular Templates, Inc. | 1.43 Million USD | 30210.629% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -619.411% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -31.981% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -214.089% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -809.053% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -209.695% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -109.163% |
| MacroGenics, Inc. | 2.01 Million USD | 21447.645% |
| RenovoRx, Inc. | -11.39 Million USD | -3680.351% |
| Adicet Bio, Inc. | -136.53 Million USD | -215.364% |
| Prime Medicine, Inc. | -193.75 Million USD | -122.226% |
| Aditxt, Inc. | -25.45 Million USD | -1591.345% |
| Adagene Inc. | -14.95 Million USD | -2779.996% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5790.236% |
| Quantum-Si incorporated | -91.8 Million USD | -369.023% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 160.44% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 440.502% |
| SciSparc Ltd. | -5.28 Million USD | -8051.874% |
| Vericel Corporation | 2.86 Million USD | 15134.288% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -452154.012% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1885.033% |
| Generation Bio Co. | -133.3 Million USD | -223.017% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -418.586% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -400.543% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -89.322% |
| Invivyd, Inc. | -196.61 Million USD | -118.998% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -15.082% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4542.495% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1685.704% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4086.505% |
| 2seventy bio, Inc. | -206.41 Million USD | -108.597% |
| ADMA Biologics, Inc. | 5.12 Million USD | 8509.805% |
| Clene Inc. | -43.24 Million USD | -895.773% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1771.365% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -788.219% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1514.555% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -43.735% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1072.31% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1926.59% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 8869.035% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1225.602% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -171.825% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 37.077% |
| Evaxion Biotech A/S | -21.4 Million USD | -1911.783% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -548.32% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -97.815% |
| Trevena, Inc. | -35.28 Million USD | -1120.194% |
| Surrozen, Inc. | -41.13 Million USD | -946.855% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -440.987% |
| Cingulate Inc. | -22.95 Million USD | -1776.008% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5671.103% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1054.902% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5134.167% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -321.041% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -534.824% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -637.652% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4843.16% |
| Kronos Bio, Inc. | -121.83 Million USD | -253.429% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -479.191% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17536.583% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -327.05% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1205.901% |
| ImmunityBio, Inc. | -436.18 Million USD | 1.284% |
| Korro Bio, Inc. | -80.9 Million USD | -432.213% |
| Kineta, Inc. | -15.71 Million USD | -2640.117% |
| BioVie Inc. | -31.95 Million USD | -1247.666% |
| Codexis, Inc. | -49.28 Million USD | -773.693% |
| Celularity Inc. | -183.94 Million USD | -134.081% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -94.385% |
| Celcuity Inc. | -58.3 Million USD | -638.436% |
| Virax Biolabs Group Limited | -6.6 Million USD | -6414.944% |
| Cibus, Inc. | -314.58 Million USD | -36.873% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1176.441% |
| IN8bio, Inc. | -28.5 Million USD | -1410.602% |
| Kodiak Sciences Inc. | -259.02 Million USD | -66.233% |
| Annexon, Inc. | -141.57 Million USD | -204.137% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -282.403% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -570.73% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1440.268% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -87.201% |
| Eyenovia, Inc. | -24.1 Million USD | -1686.2% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1061.464% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -132795.679% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -483.413% |
| Arcellx, Inc. | -64.14 Million USD | -571.264% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -856.551% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -248.717% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1294.281% |
| Moolec Science SA | -52.07 Million USD | -726.841% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -734.364% |
| Geron Corporation | -174.78 Million USD | -146.354% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -965.349% |
| Royalty Pharma plc | 1.88 Billion USD | 122.815% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -260.039% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4517.871% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1976.019% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -159.262% |
| Humacyte, Inc. | -96.45 Million USD | -346.393% |
| Structure Therapeutics Inc. | -102.45 Million USD | -320.248% |
| 89bio, Inc. | -134.46 Million USD | -220.223% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -445.904% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 10726.407% |
| Genelux Corporation | -24.16 Million USD | -1681.842% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1173.911% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -163.411% |
| Notable Labs, Ltd. | -14.4 Million USD | -2890.153% |
| Liquidia Corporation | -70.05 Million USD | -514.669% |
| Mustang Bio, Inc. | -48.06 Million USD | -795.87% |
| Immunovant, Inc. | -269.97 Million USD | -59.488% |
| Quantum-Si incorporated | -91.8 Million USD | -369.023% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -506.573% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2130.07% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -322.09% |
| Acasti Pharma Inc. | -11.3 Million USD | -3710.123% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1834.918% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2708.588% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -104.539% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -9983.078% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2611.474% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1396.323% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1062.792% |
| PepGen Inc. | -83.58 Million USD | -415.161% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1359.402% |
| United Therapeutics Corporation | 1.38 Billion USD | 131.049% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1780.517% |
| Solid Biosciences Inc. | -93.43 Million USD | -360.841% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -8923.592% |
| Immuneering Corporation | -58.06 Million USD | -641.605% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13426417.431% |
| Silo Pharma, Inc. | -3.62 Million USD | -11774.148% |
| Belite Bio, Inc | -31.52 Million USD | -1265.67% |
| XOMA Corporation | -39.36 Million USD | -993.903% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -538.401% |
| Bionomics Limited | -9.83 Million USD | -4277.17% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -412.689% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1144.241% |
| uniQure N.V. | -253.1 Million USD | -70.123% |
| Cassava Sciences, Inc. | -95.68 Million USD | -349.99% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5790.236% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -232.485% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1225.806% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5248.53% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1425.858% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -132795.679% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3764.842% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2607.893% |
| Altimmune, Inc. | -87.93 Million USD | -389.659% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -367.622% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1144.241% |
| Compugen Ltd. | -12.51 Million USD | -3340.252% |
| Peak Bio, Inc. | -1356.23 USD | -31748349.747% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -786.008% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1814.549% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -77.704% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1408.538% |
| Zura Bio Limited | -60.56 Million USD | -610.965% |
| PolyPid Ltd. | -20.26 Million USD | -2024.967% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2657.843% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1408.538% |
| Instil Bio, Inc. | -146.12 Million USD | -194.673% |
| argenx SE | -216.02 Million USD | -99.322% |
| Immunome, Inc. | -28.27 Million USD | -1423.052% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -788.292% |
| Verona Pharma plc | -52.46 Million USD | -720.663% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -354.335% |
| Shattuck Labs, Inc. | -87.61 Million USD | -391.448% |
| CervoMed Inc. | -2.17 Million USD | -19725.367% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -252.232% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3292.279% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -793.806% |
| Moolec Science SA | -52.07 Million USD | -726.841% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2412.149% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -230.224% |
| AnaptysBio, Inc. | -143.16 Million USD | -200.761% |
| Design Therapeutics, Inc. | -66.32 Million USD | -549.2% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -431.668% |
| NeurAxis, Inc. | -6.66 Million USD | -6360.835% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1040.615% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1077.419% |
| Achilles Therapeutics plc | -70.44 Million USD | -511.257% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -354.335% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1845.34% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 7486.58% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17536.583% |
| Nutriband Inc. | -5.12 Million USD | -8306.887% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -292.337% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -676.775% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -751.794% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -559.623% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -695.754% |
| Palisade Bio, Inc. | -12.28 Million USD | -3406.083% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -848.92% |
| Beam Therapeutics Inc. | -156.47 Million USD | -175.18% |
| Neurogene Inc. | -52.28 Million USD | -723.513% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -215.468% |
| AEON Biopharma, Inc. | -48.36 Million USD | -790.35% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -362.902% |
| Sesen Bio, Inc. | -50.84 Million USD | -746.935% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -425.536% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3386.487% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -0.737% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -309.31% |
| Athira Pharma, Inc. | -116.7 Million USD | -268.955% |
| Vaccinex, Inc. | -19.74 Million USD | -2080.383% |
| HCW Biologics Inc. | -23.57 Million USD | -1726.353% |
| XOMA Corporation | -39.36 Million USD | -993.903% |
| Nektar Therapeutics | -243.1 Million USD | -77.116% |
| Arvinas, Inc. | -394.8 Million USD | -9.063% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 228276.105% |
| Merus N.V. | -149.2 Million USD | -188.58% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -360.565% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1277.422% |
| Rezolute, Inc. | -68.42 Million USD | -529.294% |
| Clene Inc. | -43.24 Million USD | -895.773% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2691.964% |
| BeyondSpring Inc. | -21.54 Million USD | -1898.988% |
| Synlogic, Inc. | -55.16 Million USD | -680.591% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3463.536% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3946.063% |
| Peak Bio, Inc. | -1356.23 USD | -31748349.747% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1226.296% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2504.949% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -263.597% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -26.142% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -9247.408% |
| MannKind Corporation | 15.12 Million USD | 2946.07% |
| Ikena Oncology, Inc. | -74.39 Million USD | -478.763% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3319.217% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2218.276% |
| Gossamer Bio, Inc. | -172.15 Million USD | -150.117% |
| CohBar, Inc. | -12.06 Million USD | -3468.628% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1587.961% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1334.078% |
| Legend Biotech Corporation | -477.87 Million USD | 9.896% |
| Mural Oncology plc | -192.72 Million USD | -123.424% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -277.525% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2566.924% |
| Disc Medicine, Inc. | -91.02 Million USD | -373.037% |
| Champions Oncology, Inc. | -5.05 Million USD | -8419.628% |
| REGENXBIO Inc. | -239.46 Million USD | -79.811% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3917.303% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -672.261% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1010.656% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -281.701% |
| Vaxart, Inc. | -74.72 Million USD | -476.238% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1122.956% |
| Cellectis S.A. | -98.09 Million USD | -338.944% |
| Longeveron Inc. | -20.06 Million USD | -2046.471% |
| Repare Therapeutics Inc. | -114.27 Million USD | -276.801% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 1.961% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -475.552% |
| Revolution Medicines, Inc. | -430.58 Million USD | -0.0% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6746.589% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1298.493% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -477.265% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 8882.011% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3826.876% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 109.35% |
| Denali Therapeutics Inc. | -179.97 Million USD | -139.248% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -452154.012% |
| Veru Inc. | -89.97 Million USD | -378.554% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1501.987% |
| Cingulate Inc. | -22.95 Million USD | -1776.008% |
| Passage Bio, Inc. | -98.34 Million USD | -337.846% |
| Context Therapeutics Inc. | -25.06 Million USD | -1618.165% |
| Exicure, Inc. | -15.53 Million USD | -2670.976% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -108.955% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1064.49% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -7121.385% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -155.593% |
| Nuvalent, Inc. | -149.49 Million USD | -188.03% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5194.639% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -401.295% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1326.808% |
| OmniAb, Inc. | -49.73 Million USD | -765.822% |
| Anew Medical, Inc. | -1.3 Million USD | -33000.304% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3382.546% |
| Lipocine Inc. | -16.32 Million USD | -2537.939% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -545.841% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -479.495% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1029.152% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1003.66% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1841.045% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 21.004% |
| Ocugen, Inc. | -64.82 Million USD | -564.202% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -365.142% |
| Q32 Bio Inc. | -86.5 Million USD | -397.771% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2443.758% |
| Alumis Inc. Common Stock | -156.89 Million USD | -174.448% |
| Equillium, Inc. | -12.13 Million USD | -3447.388% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -636.39% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5348.095% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2182.926% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -822.175% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -304.892% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2307.289% |
| Dominari Holdings Inc. | -22.44 Million USD | -1818.815% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5157.32% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1594.404% |
| Bio-Techne Corporation | 326.66 Million USD | 231.812% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -11.879% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 298.985% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -228.418% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1050.335% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -184.963% |
| Nkarta, Inc. | -120.48 Million USD | -257.386% |
| BioCardia, Inc. | -11.56 Million USD | -3624.758% |
| Iterum Therapeutics plc | -34.58 Million USD | -1145.176% |